MedPath

Depression in Pregnant women due to COVID-19 pandemic in India

Completed
Conditions
Coronavirus as the cause of diseases classified elsewhere,
Registration Number
CTRI/2021/05/033545
Lead Sponsor
JSS college of Pharmacy Ooty
Brief Summary

The COVID-19 pandemic has affected the pregnant women both physically and mentally. The perceptions, appetite, sleep cycle, behavioral patterns, impact is not only with the pregnant women but also the newborn babies. However, there are only limited studies stating the major complications faced by the pregnant women during this pandemic. Owing to the rapid increase in the virus spread India, mortality rate there is an increased burden among the pregnant women than that of the general population.

When compared to other countries, only limited studies are conducted about the substantial increase in conditions like anxiety, stress, depression and panic in pregnant women who are undertaking medical care or want to seek medical care during this pandemic. Thus, this study focuses on to determine whether the COVID-19 pandemic is associated with antenatal depression during pregnancy and depression among non-pregnant women using Edinburgh Postnatal Depression Scale (EPDS), and to assess the maternal outcomes at delivery and neonatal outcomes at birth in Obstetrics and Gynecology department of Government Medical College Hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Maternal age of 18 years or greater at the time of consent.
  • Gestational week: 32 to 40 weeks (Third trimester) The ability to provide written informed consent.
Exclusion Criteria
  • Pregnant women with the gestational week under six (Early first trimester) Pregnant women with chronic disease like chronic hypertension, kidney and liver disease, pre-pregnancy diabetes mellitus Patient with reported depression in the past History of use of anti-depressants and other drugs which cause depression.
  • History of high-risk pregnancy including abruption placenta, placenta previa, gestational diabetes, coagulation disorders, thrombocytopenia or history of drug abuse.
  • History of autoimmune diseases.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether COVID-19 pandemic is a possible risk factor for the development of depression among the pregnant and non-pregnant women.6 months
Secondary Outcome Measures
NameTimeMethod
Whether the COVID-19 pandemic has an impact on the maternal outcomes at delivery and neonatal outcomes at birth6 months

Trial Locations

Locations (1)

Government Medical College and Hospital, Ooty

🇮🇳

Nilgiris, TAMIL NADU, India

Government Medical College and Hospital, Ooty
🇮🇳Nilgiris, TAMIL NADU, India
ShonithaS
Principal investigator
6384845560
shonithasagadevan@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.